Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Clinical Chair in Respiratory Medicine







G05Emmanuel Kaye BuildingRoyal Brompton Campus





Wisia Wedzicha is Professor of Respiratory Medicine at the National Heart and Lung Institute, Imperial College, UK. She qualified from Somerville College, Oxford University and St Bartholomew’s Hospital Medical College, University of London. She was elected as Fellow of the Academy of Medical Sciences (FMedSci) in 2013 and is an NIHR Senior Investigator.

Professor Wedzicha has a major interest in the causes, mechanisms, impact and prevention of chronic obstructive pulmonary disease (COPD) exacerbations, and in the role of bacterial and viral infection in COPD exacerbations. She directs an active research group specialising in COPD exacerbations, and has published extensively on this topic.

Professor Wedzicha chaired the English Department of the Health Home Oxygen Clinical User Group, and was a member of the Guideline Development Group for the revision of the National Institute for Healthcare and Clinical Excellence COPD Guidelines. She was a member of the Programme Board for the COPD National Clinical Strategy.

Professor Wedzicha was Editor-in-Chief of Thorax from 2002 to 2010, and is a member of the BioMed Central advisory board. She is currently Editor in Chief for the American Journal of Respiratory and Critical Care Medicine. In addition, she is on the editorial boards of a number of international journals. She was  the Lancet Ombudsman till 2014, Publications Director for the European Respiratory Society (ERS) and has also previously been ERS Guidelines Director.


Wedzicha JA, 2016, Eosinophils as Biomarkers of Chronic Obstructive Pulmonary Disease Exacerbation Risk. Maybe Just for Some?, American Journal of Respiratory and Critical Care Medicine, Vol:193, ISSN:1073-449X, Pages:937-938

Wedzicha JA, Donaldson G, Augusti A, et al., 2016, Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, PlaceboControlled Studies, Copd: Journal of Chronic Obstructive Pulmonary Disease, ISSN:1541-2555

Rothnie KJ, Smeeth L, Pearce N, et al., 2016, Predicting mortality after acute coronary syndromes in people with chronic obstructive pulmonary disease, Heart, Vol:102, ISSN:1355-6037, Pages:1442-1448

Brill SE, Law M, El-Emir E, et al., 2015, Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial, Thorax, Vol:70, ISSN:0040-6376, Pages:930-938

Alahmari AD, Mackay AJ, Patel ARC, et al., 2015, Influence of weather and atmospheric pollution on physical activity in patients with COPD, Respiratory Research, Vol:16, ISSN:1465-993X

More Publications